Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 48 of 1,261
  1. US 12281140

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  2. US 12281329

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Fate Therapeutics, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  3. US 12281327

    Lymphohematopoietic engineering using CAS9 base editors

    Regents of the University of Minnesota · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  4. US 12281321

    Frataxin expression constructs having engineered promoters and methods of use thereof

    VOYAGER THERAPEUTICS, INC. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  5. US 12281164

    Genetically engineered dual-targeting chimeric antigen receptor and use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  6. US 12280057

    Vasoactive topical compound to affect tissue blood flow, reduce tissue necrosis and promote healing

    SOUTH DAKOTA BOARD OF REGENTS · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  7. US 12280142

    Compositions for preventing infection

    Altamira Medica AG · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  8. US 12280032

    Methods and compositions for increasing the potency of antifungal agents

    PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  9. US 12280046

    Melanocortin subtype-2 receptor (MC2R) antagonist for the treatment of disease

    CRINETICS PHARMACEUTICALS, INC. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  10. US 12281336

    Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and E2 structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  11. US 12281136

    Crystalline forms of a CD73 inhibitor and uses thereof

    Arcus Biosciences, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  12. US 12281078

    Quinoline cGAS antagonist compounds

    The Board of Regents of the University of Texas System · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  13. US 2025120959

    NEW FORMULATIONS OF PITOLISANT AND METHODS OF USE

    BIOPROJET PHARMA [FR] · Granted Apr 17, 2025 · Expires Apr 12, 2045

    granted
  14. WO 2025078995

    COMPOSÉS DE 6-(PYRIMIDIN-4-YL)QUINOLÉINE SUBSTITUÉS UTILISÉS EN TANT QU'INHIBITEURS DE KINASE DÉPENDANTE DE LA CYCLINE

    BEIGENE SWITZERLAND GMBH [CH] · Granted Apr 17, 2025 · Expires Apr 12, 2045

    granted
  15. WO 2025077836

    LIPIDES IONISABLES ET NANOPARTICULES LIPIDIQUES POUR ADMINISTRATION D'ARN

    BEIGENE SWITZERLAND GMBH [CH] · Granted Apr 17, 2025 · Expires Apr 12, 2045

    granted
  16. TW 202515903

    Anti-PD-1-based treatment before and after surgery

    BEIGENE SWITZERLAND GMBH [CH] · Granted Apr 16, 2025 · Expires Apr 11, 2045

    granted
  17. TW 202515875

    Solid forms comprising a B-RAF kinase dimer inhibitor, methods of preparation, and uses therefor

    BEIGENE SWITZERLAND GMBH [CH] · Granted Apr 16, 2025 · Expires Apr 11, 2045

    granted
  18. US 12274710

    Compound for regulating body weight imbalance, composition thereof and application thereof

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  19. US 12275788

    Single-domain antibodies against CD33 and constructs thereof

    Legend Biotech Ireland Limited · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  20. US 12275786

    Anti-thyroglobulin t cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  21. US 12274747

    Compositions and methods for treating cytokine release syndrome

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  22. US 12275792

    Antigen-binding proteins that activate the leptin receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  23. US 12275685

    Oligo-benzamide analogs and their use in cancer treatment

    The Board of Regents of the University of Texas System · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  24. US 12274741

    Cattle fever tick-infestation vaccines and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.